Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

BYAHBYAH
6 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PARK HA BIOLOGICAL TECH CO L

No. Citadel Advisors exited its BYAH (Park Ha Biological Tech) position in Q1 2026. Its Q4 2025 13F listed 93,828 shares worth $14,919. Citadel Advisors first reported BYAH in Q4 2024 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$187,071

Total Shares Change

-29,741

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$8.40
0
2025-Q4
New
93,828
-
$14,9190.0%$63.60
28
2025-Q3
Exited
0
-100.0%
$00.0%$191.20
0
2025-Q2
Increased
21,234
+27.9%
$742,9780.0%$13,996.00
31
2025-Q1
Decreased
16,606
-44.2%
$219,5310.0%$5,288.00
0
2024-Q4
New
29,741
-
$187,0710.0%$2,516.00
35

Other major holders of BYAH: Invesco Ltd., GEODE CAPITAL MANAGEMENT, LLC, BNP PARIBAS FINANCIAL MARKETS, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used